View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
PRI Bio|30 May 2017

AutoFlow™ Efficient Sterilization Systems

The AutoFlow™ is designed for multi-purpose processing and production facilities with biowaste effluent and low solids content.

AutoFlow for multi-purpose processing and production facilities

The AutoFlow™ is designed for multi-purpose processing and production facilities with biowaste effluent and low solids content.

Key features:

  • High throughput of 500l to more than 6,000l per hour
  • Small batch models available from 500l to 4,000l per day
  • High-efficiency, easy installation, and low-operating cost
  • Fully automatic, easy-to-use, and continuous operation
  • A compact design, modular, flexible, and energy efficient
  • Hygienic construction manufactured to good manufacturing practice (GMP) standards
  • Safe and reliable operation, self-cleaning clean-in-place (CIP), and sterile filter options

PRI Bio's AutoFlow is designed for applications in biologics, virology, vaccine, genetically modified organism (GMO), and contract manufacturing organization (CMO) pilot plant research labs through...
PRI BIO's skid-mounted, multi-stage, continuous flow and batch waste neutralization systems are designed for pharmaceutical industry applications.
The AutoFlow SB is designed for laboratory applications such as research, virology, vaccine, and genetically modified organisms (GMO) in contract manufacturing organisation (CMO), forensic, hospitals,...
The AutoFlow SINK was designed for small laboratory applications such as research, virology, vaccines, and genetically modified organisms (GMO) in contract research organisations (CMO), hospitals,...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology